Literature DB >> 8996494

High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study.

D Tanne1, S Yaari, U Goldbourt.   

Abstract

BACKGROUND AND
PURPOSE: While there is overwhelming evidence relating low levels of HDL cholesterol (HDL-C) with coronary heart disease, the association with cerebrovascular disease is not clear. The aim of the present report was to assess the association between HDL-C levels and ischemic stroke mortality obtained from a long-term follow-up in the Israeli Ischemic Heart Disease Study.
METHODS: The subjects of this report are 8586 men, tenured civil servants and municipal employees, aged 42 years or older at the time of HDL-C measurements in 1965. They were followed up for mortality for 21 years. Death due to cerebrovascular disease included the International Classification of Disease, 9th Revision, codes 430 to 438, of which presumed ischemic stroke included codes 433 to 438.
RESULTS: During the 21-year follow-up, 295 men died from cerebrovascular events, of which 241 deaths were due to presumed ischemic stroke. Individuals subsequently experiencing a fatal ischemic stroke had a marginally lower age-adjusted mean HDL-C (1.05 mmol/L) and a significantly lower (P < .001) age-adjusted mean percentage of serum cholesterol contained in the HDL fraction (%HDL) (19.3%) than counterparts surviving the follow-up period (1.06 mmol/L and 20.6%, respectively). Decreasing age-adjusted rates of ischemic stroke mortality were observed with increasing %HDL: 14.6, 14.0, and 11.8 per 10,000 person-years in the low, middle, and upper tertiles of %HDL, respectively. In multivariate analysis, a low concentration of HDL-C appeared to be significantly predictive of ischemic stroke mortality. The relative risk associated with a 5% decrease of %HDL was 1.18 (95% confidence interval, 1.03 to 1.34). Men at the lower tertile of HDL-C levels experienced a 1.32-fold increase of covariate-adjusted ischemic stroke mortality risk compared with counterparts at the upper tertile.
CONCLUSIONS: In this prospective study of middle-aged and elderly men from a healthy, working population, we have demonstrated an independent negative association between HDL-C and ischemic stroke mortality during a long-term (21-year) follow-up.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996494     DOI: 10.1161/01.str.28.1.83

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  32 in total

Review 1.  The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.

Authors:  C Sarti; M Kaarisalo; J Tuomilehto
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  A study of serum apolipoprotein A1, apolipoprotein B and lipid profile in stroke.

Authors:  Shilpasree As; Savitri Sahukar; Jayaprakash Murthy; Kiran Kumar
Journal:  J Clin Diagn Res       Date:  2013-07-01

Review 3.  Stroke Risk Factors, Genetics, and Prevention.

Authors:  Amelia K Boehme; Charles Esenwa; Mitchell S V Elkind
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

4.  What is the association of lipid levels and incident stroke?

Authors:  Stephen P Glasser; Aleena Mosher; George Howard; Maciej Banach
Journal:  Int J Cardiol       Date:  2016-06-23       Impact factor: 4.164

5.  Polymorphisms in the GCKR are associated with serum lipid traits, the risk of coronary artery disease and ischemic stroke.

Authors:  Yi-Jiang Zhou; Shao-Cai Hong; Rui-Xing Yin; Qian Yang; Xiao-Li Cao; Wu-Xian Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  HDL cholesterol and stroke risk: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Samantha A Reina; Maria M Llabre; Matthew A Allison; John T Wilkins; Armando J Mendez; Martinson K Arnan; Neil Schneiderman; Ralph L Sacco; Mercedes Carnethon; J A Chris Delaney
Journal:  Atherosclerosis       Date:  2015-09-28       Impact factor: 5.162

7.  Vitamin D status, serum lipid concentrations, and vitamin D receptor (VDR) gene polymorphisms in Familial Mediterranean fever.

Authors:  Turan Turhan; Halef Okan Doğan; Nihal Boğdaycioğlu; Nilnur Eyerci; Ahmet Omma; İsmail Sari; Ahmet Yeşilyurt; Yaşar Karaaslan
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

8.  Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort study.

Authors:  P M Rist; J E Buring; C S Kase; P M Ridker; T Kurth
Journal:  Eur J Neurol       Date:  2012-10-03       Impact factor: 6.089

9.  Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS).

Authors:  Joshua Z Willey; Qiang Xu; Bernadette Boden-Albala; Myunghee C Paik; Yeseon Park Moon; Ralph L Sacco; Mitchell S V Elkind
Journal:  Arch Neurol       Date:  2009-11

Review 10.  Dyslipidemias in the prevention of cardiovascular disease: risks and causality.

Authors:  Ian Graham; Marie-Therese Cooney; David Bradley; Alexandra Dudina; Zeljko Reiner
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.